Return-path: <bounce-18416124_HTML-982008319-36134973-10831468-449@bounce.broadcastemail.asco.org>
Envelope-to: info@seeinindia.com
Delivery-date: Tue, 02 Jun 2015 00:07:07 +0000
Received: from mta.broadcastemail.asco.org ([64.132.92.206]:59471)
	by bh-in-11.webhostbox.net with esmtp (Exim 4.85)
	(envelope-from <bounce-18416124_HTML-982008319-36134973-10831468-449@bounce.broadcastemail.asco.org>)
	id 1YzZjW-003xGP-Ap
	for info@seeinindia.com; Tue, 02 Jun 2015 00:07:07 +0000
Received: by mta.broadcastemail.asco.org id hdjpqk163hsh for <info@seeinindia.com>; Mon, 1 Jun 2015 18:06:59 -0600 (envelope-from <bounce-18416124_HTML-982008319-36134973-10831468-449@bounce.broadcastemail.asco.org>)
From: "Daily News" <dailynews@asco.org>
To: <info@seeinindia.com>
Subject: View Monday's Highlights of the Day Video from the 2015 ASCO Annual Meeting
Date: Mon, 01 Jun 2015 18:06:57 -0600
List-Unsubscribe: <mailto:leave-fc5015787165027c77101f2d205921-fe271d7877640475761579-fe5b1776746700747217-fe6015707d670579731c-ff5e10747c@leave.broadcastemail.asco.org>
MIME-Version: 1.0
x-job: 10831468_36134973
Message-ID: <0ca81936-9291-4947-9615-78debffa58e0@xtinmta06.xt.local>
Content-Type: multipart/alternative;
	boundary="D3aH951gzsxU=_?:"
X-Authenticated_sender: 

This is a multi-part message in MIME format.

--D3aH951gzsxU=_?:
Content-Type: text/plain;
	charset="us-ascii"
Content-Transfer-Encoding: 7bit

To view this email as a web page, go to the link below, or copy and paste it into your browser's address window.
http://click.broadcastemail.asco.org/?qs=f885b89315503948e0c21d45f18d1238d5b25d24d5929dcb7b382ec929a0008b8273da764f0d2a5dASCO
http://click.broadcastemail.asco.org/?qs=f885b893155039480ac80f3af0acb2a8d4a5de767480afc01d2bc6b1aa78ea2d67f6ec9cb8df1a10 
Advertisement
http://click.broadcastemail.asco.org/?qs=f885b893155039480ac80f3af0acb2a8d4a5de767480afc01d2bc6b1aa78ea2d67f6ec9cb8df1a10 

 

http://click.broadcastemail.asco.org/?qs=f885b89315503948c36278594548106dad9c6f88c321eb4b327c15c7b287ffd43c0160913ccfb4db 

http://click.broadcastemail.asco.org/?qs=f885b8931550394896574f07ea2cd42ef6855c82fdf7cc23e87a37e03f0ed37b746df1e23ce35c4a 

http://click.broadcastemail.asco.org/?qs=f885b8931550394896574f07ea2cd42ef6855c82fdf7cc23e87a37e03f0ed37b746df1e23ce35c4a 
View Monday's Highlights of the Day Video 
 

Gastrointestinal (Noncolorectal) Cancer 

Dr. Eileen Mary O'Reilly 


Genitourinary (Prostate) Cancer 

Dr. Robert Dreicer 


Health Services Research and Quality of Care 

Dr. Blase N. Polite 


Lung Cancer - Non-Small Cell Metastatic 

Dr. Edward B. Garon


 


Educational Highlights from Today's Sessions 


2015 ASCO Educational Book Articles:

	- 
http://click.broadcastemail.asco.org/?qs=f885b89315503948777bfcf9ccf76531c42f3b2841867212045880167e8d20177e7cafa44154cc85 
Management of Chronic Lymphocytic Leukemia  - Dr. Stephan Stilgenbauer; Dr. Richard R. Furman; and Dr. Clive S. Zent

	- 
http://click.broadcastemail.asco.org/?qs=f885b893155039489bcd3d82e0f2be40339049d2f6d8e23523a58adf823e9edddf7f4acd5e04072b 
What Can We Learn about Antibody-Drug Conjugates from the T-DM1 Experience?  - Dr. Francisco J. Esteva; Dr. Kathy D. Miller; and Dr. Beverly A. Teicher
	- 
http://click.broadcastemail.asco.org/?qs=f885b8931550394851af076f6a2cbd3e543e4f374a78a4e95b08dd396b2593a9a6298397b5a71d5d 
New and Promising Strategies in the Management of Bladder Cancer  - Dr. Andrea B. Apolo; Dr. Nicholas J. Vogelzang; and Dr. Dan Theodorescu
	- 
http://click.broadcastemail.asco.org/?qs=f885b893155039488521ea990996aa5f62f85b77670e9d19b539af26e00c0f66aafdaba1404a2ad6 
Nonsurgical Management of Cervical Cancer: Locally Advanced, Recurrent, and Metastatic Disease, Survivorship, and Beyond  - Dr. Helen J. Mackay; Dr. Lari B. Wenzel; and Dr. Linda R. Mileshkin
	- 
http://click.broadcastemail.asco.org/?qs=a73cfe5fc9bf5a97bcc7e00bf7f070c73a78f2cb1b7a09674fadf35b2647eeed36c18fb4865830df 
Managing Immune Checkpoint-Blocking Antibody Side Effects  - Dr. Michael A. Postow

http://click.broadcastemail.asco.org/?qs=a73cfe5fc9bf5a97e7de89d7ff02f1998aec272c94c7b0fbbd435f4022e732afb3f90a83177cf9f9 
Read more from the  2015 ASCO Educational Book » 

 

http://click.broadcastemail.asco.org/?qs=a73cfe5fc9bf5a978a8758dcfbb2d1aeea41ab2519d3ef72b250e8c4444388bd1b7c2f7e68f64c4c 
PROCLAIM Trial: Safety Benefit with Pemetrexed Regimen in NSQ NSCLC 

http://click.broadcastemail.asco.org/?qs=a73cfe5fc9bf5a978a8758dcfbb2d1aeea41ab2519d3ef72b250e8c4444388bd1b7c2f7e68f64c4c 
 
In patients with advanced nonsquamous non-small cell lung cancer, a chemotherapy regimen including pemetrexed had a better safety profile than one including etoposide; however, the pemetrexed arm did not demonstrate improved OS, according to the final phase III PROCLAIM trial results (Abstract 7506), presented by Dr. Suresh Senan (pictured).

http://click.broadcastemail.asco.org/?qs=a73cfe5fc9bf5a978a8758dcfbb2d1aeea41ab2519d3ef72b250e8c4444388bd1b7c2f7e68f64c4c 
Read the Full Story » 

 

http://click.broadcastemail.asco.org/?qs=a73cfe5fc9bf5a97281375e6641beebec14e491fcc55b67f087f2480e69566a7e37af6376277f16a 
 
http://click.broadcastemail.asco.org/?qs=a73cfe5fc9bf5a97281375e6641beebec14e491fcc55b67f087f2480e69566a7e37af6376277f16a 
Clinical Trial Designs for Studying Targeted Therapies 

During the Education Session "Improving Clinical Trial Efficiency: Thinking Outside the Box," 
Drs. Richard Simon (pictured), Sumithra J. Mandrekar, and Suzanne Dahlberg discussed several strategies to address the challenge of understanding drug activity in molecularly defined subsets of patients. 

http://click.broadcastemail.asco.org/?qs=a73cfe5fc9bf5a97281375e6641beebec14e491fcc55b67f087f2480e69566a7e37af6376277f16a 
Read the Full Story » 

 

http://click.broadcastemail.asco.org/?qs=a73cfe5fc9bf5a97c4fd0f10823618d5ad7927040303e82970aaf1e19a7e3975ef32484919b01b90 
Opportunities and Challenges of Incorporating Technology into Practice 

http://click.broadcastemail.asco.org/?qs=a73cfe5fc9bf5a97c4fd0f10823618d5ad7927040303e82970aaf1e19a7e3975ef32484919b01b90 
 
During the Education Session "The Challenge to Stay Current: Incorporating Technology into Practice," Dr. Michael A. Thompson (pictured), Dr. Jeremy Warner, and Dr. Laura E. Strong explored topics related to information retrieval, social media, and the application of technology to patient-reported outcomes.


http://click.broadcastemail.asco.org/?qs=a73cfe5fc9bf5a97c4fd0f10823618d5ad7927040303e82970aaf1e19a7e3975ef32484919b01b90 
Read the Full Story » 

 

http://click.broadcastemail.asco.org/?qs=a73cfe5fc9bf5a977fd3693bbfd772ec7bad2eebc74e1874546a4f453add97d1c0c180f26e830622 
ASCO Daily News Home
http://click.broadcastemail.asco.org/?qs=f885b89315503948c36278594548106dad9c6f88c321eb4b327c15c7b287ffd43c0160913ccfb4db 
 | 
http://click.broadcastemail.asco.org/?qs=a73cfe5fc9bf5a975b4271270c6288e7cefa28449df8f621aa9ad4ac06e2b66cc48fec50971ea740 
Session Coverage  | 
http://click.broadcastemail.asco.org/?qs=a73cfe5fc9bf5a97e7ad54093178779985e7518bd2e7b8789ec9c71d9655f3e136c31dfac1edd461 
Expert Editorials 

http://click.broadcastemail.asco.org/?qs=a73cfe5fc9bf5a972d381db1e460b55a0f1f9e9ae05e3b95e412c76e2ad64be0299f9320ee92aff2 
Grants and Awards  | 
http://click.broadcastemail.asco.org/?qs=a73cfe5fc9bf5a9704e6f4613ebd9265c7be469ec340f6031f2db2763f114defff0e06a37483264f 
am.asco.org 

Connect with us:
http://click.broadcastemail.asco.org/?qs=c1a7c58a1afee74f8488fbd5303069fbe7fbd32c30212ff4f08c8379c6b6a53b2166beb640b8a0f6 

http://click.broadcastemail.asco.org/?qs=c1a7c58a1afee74ff99c2658e366b74ec313e89790c94a2483c3d5c8dd5520e26a0a48555dd50f79 

http://click.broadcastemail.asco.org/?qs=c1a7c58a1afee74f7cd33b278497ea152916868702aefa5db423f0caaa2ffad5305fb582ede20426 

http://click.broadcastemail.asco.org/?qs=c1a7c58a1afee74fcb1a18b062f926560294a94cbf7e7ae15fcff9cc5aba2c38e31f9c561a396a8c 
Forward to a Colleague 
http://click.broadcastemail.asco.org/?qs=c1a7c58a1afee74fcb1a18b062f926560294a94cbf7e7ae15fcff9cc5aba2c38e31f9c561a396a8c 

 
http://click.broadcastemail.asco.org/?qs=c1a7c58a1afee74f4c79806ba8b01f8609f39b3774a8e529483c6714074d35204715294fd9de9f11 

Advertisement








You are receiving this email because you have an existing relationship
with ASCO.  Visit your personalized 
http://click.broadcastemail.asco.org/?qs=c1a7c58a1afee74fa246f4fa799aa4f80c2d5508513c38468be973543fb42a5e56accd063a9450c2 
Preference Center  to unsubscribe or to select
your preferences for receiving ASCO promotional email.  Please do
not reply to this email.  

This email was sent by: American Society of Clinical Oncology

2318 Mill Road, Suite 800 Alexandria, VA,
22314, USA



--D3aH951gzsxU=_?:
Content-Type: text/html;
	charset="us-ascii"
Content-Transfer-Encoding: 7bit

<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<div style="display:block;width:100%;text-align:center;font-family: Verdana, sans-serif;font-size:10px;color:#444444;padding:8px 0;margin:auto;">
	To view this email as a web page, go   <a href="http://click.broadcastemail.asco.org/?qs=15def1ccdbbce4763640c5b7279f5819a0e66084de54f26f8f5358d12d2bae5872d246dde59e0560" > here</a>.
</div><!DOCTYPE html>
<html lang="en">

<head>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
    <title>ASCO</title>

    <style>
        
        body {margin:0; padding:0; -webkit-text-size-adjust:none; -ms-text-size-adjust:none;} img{line-height:100%; outline:none; text-decoration:none; -ms-interpolation-mode: bicubic;} a img{border: none;} #backgroundTable {margin:0; padding:0; width:100% !important; } a, a:link{color:#318786; text-decoration: none;} table td {border-collapse:collapse;} span {color: inherit; border-bottom: none;} span:hover { background-color: transparent; }

    </style>
</head><body style="background: #d8d8d8;font-family:Arial, Helvetica, sans-serif; font-size:1em;">


    <table id="backgroundTable" width="100%" cellspacing="0" cellpadding="0" border="0" style="background:#d8d8d8;">
        <tr>
            <td class="body" align="center" valign="top" style="background:#d8d8d8;" width="100%">
                <table cellpadding="0" cellspacing="0">
                    <tr>
                        <td class="banner" width="826" align="center" style="background: #d8d8d8; padding-top: 16px;">
                            <table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><div style="text-align: center;"><a href="http://click.broadcastemail.asco.org/?qs=15def1ccdbbce476745ee327d150ea8fe683b2140624476eafbd45f4d94eeaa54a84371ee1942a33" title="http://ad.doubleclick.net/ddm/clk/288272216;115211492;z"  >
<img src="http://image.broadcastemail.asco.org/lib/fe6015707d670579731c/m/1/Votrient+aRCC_10301R0_ReThink_728x90.jpg" title="Votrient aRCC_10301R0_ReThink_728x90" alt="Votrient aRCC_10301R0_ReThink_728x90" border="0" width="728" height="90" style="width: 728px; height: 90px; border-color: #000000; margin: 0px;" /></a></div><div style="text-align: center;">Advertisement</div><a href="http://click.broadcastemail.asco.org/?qs=15def1ccdbbce476745ee327d150ea8fe683b2140624476eafbd45f4d94eeaa54a84371ee1942a33" title="http://ad.doubleclick.net/ddm/clk/288272216;115211492;z"  >
<br /></a></td></tr></table></td></tr></table>&nbsp;
                        </td>
                    </tr>
                    <tr>
                       
                    </tr>
                    <tr>
                        <td class="main" width="826" align="center">
                            <table cellpadding="0" cellspacing="0">
	<tr>
        <td class="header" width="826" align="left">
            <table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><div style="text-align: center;">
<a href="http://click.broadcastemail.asco.org/?qs=15def1ccdbbce4760a507c70abfe8b57b63bd1779654dd39a4cc6bd45139ddc736875edcdadf5028" title="AM Daily News"  ><img width="826" height="115" border="0" alt="NNB banner" title="NNB banner" src="http://image.broadcastemail.asco.org/lib/fe6015707d670579731c/m/1/NNB+banner.png" style="width: 826px; height: 115px; border-color: #000000; margin: 0px;" /></a>
</div>
<div style="text-align: center;">
</div></td></tr></table></td></tr></table>
        </td>
    </tr>
    <tr>
    	<td class="subheader" width="826" align="left">
    		
    	</td>
    </tr>
    <tr>
    	<td width="826" style="background: #d8d8d8;">
    		<table cellpadding="0" cellspacing="0">
    			<tr>
    				<td style="padding: 16px;">
    					<table cellpadding="0" cellspacing="0">
    						<tr>
    							<td width="618" valign="top">
    								<table cellpadding="0" cellspacing="0">
    									<tr>
    										<td width="618"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table cellspacing="0" cellpadding="0" class="dashedBorder">
	<tbody>
		<tr>
			<td width="618" align="left" style="background: #ffffff none repeat scroll 0% 0%;">
			<a href="http://click.broadcastemail.asco.org/?qs=15def1ccdbbce4767d1610b8126599b4ec5d53a8930f9a73286792e1bc2876801e1350d8d10c4bcd" title=" Highlights of the Day Session II "  ><img width="618" height="200" style="display: block; border: 0px none; width: 618px; height: 200px; margin: 0px;" alt="HOD_1x" src="http://image.broadcastemail.asco.org/lib/fe6015707d670579731c/m/1/Highlights.jpg" title="HOD_1x" dontmaintainaspect="true" thid="f0706b09-9122-48b0-bd01-006a80a82c4e" /></a>
			</td>
		</tr>
		<tr>
			<td width="618" align="left" style="background: #ffffff none repeat scroll 0% 0%;">
			<table cellspacing="0" cellpadding="0">
				<tbody>
					<tr>
						<td style="padding: 20px 24px;">
						<table cellspacing="0" cellpadding="0">
							<tbody>
								<tr>
									<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786; padding-bottom: 12px;"><a title="Highlights of the Day Session II" style="text-decoration: none; color: #318786;" href="http://click.broadcastemail.asco.org/?qs=15def1ccdbbce476021b506db3357b8af494e4e17d74caee77a30b8cb65a511fc03479e51f72c50b"  >View Monday's Highlights of the Day Video 
									</a></td>
								</tr>
								<tr>
									<td align="left" style="font-family: arial,sans-serif; font-size: 14px; color: #747474; padding-bottom: 16px; line-height: 18px ! important;">
									<p>
									<b>Gastrointestinal (Noncolorectal) Cancer </b><br />
									Dr. Eileen Mary O'Reilly 
									</p>
									 
									<p>
									<b>Genitourinary (Prostate) Cancer </b><br />
									Dr. Robert Dreicer 
									</p>
									<p>
									<b>Health Services Research and Quality of Care </b><br />
									Dr. Blase N. Polite 
									</p>
									<p>
									<b>Lung Cancer - Non-Small Cell Metastatic </b><br />
									Dr. Edward B. Garon
									</p>
									</td>
								</tr>
							</tbody>
						</table>
						</td>
					</tr>
				</tbody>
			</table>
			</td>
		</tr>
		<tr>
			<td width="618" height="16" style="font-size: 1px;">&nbsp;</td>
		</tr>
	</tbody>
</table>
<br /></td></tr></table></td></tr></table></td>
    									</tr>
    									<tr>
    										<td width="618"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table cellspacing="0" cellpadding="0" class="dashedBorder">
	<tbody>
		<tr>
			<td width="618" align="left" style="background: #ffffff none repeat scroll 0% 0%;">
			<table cellspacing="0" cellpadding="0">
				<tbody>
					<tr>
						<td style="padding: 20px 24px;">
						<table cellspacing="0" cellpadding="0">
							<tbody>
								<tr>
									<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786; padding-bottom: 12px;">
									Educational Highlights from Today's Sessions 
									</td>
								</tr>
								<tr>
									<td align="left" style="font-family: arial,sans-serif; font-size: 14px; color: #747474; padding-bottom: 16px; line-height: 18px ! important;">
									<p>
									<font size="3"><i>2015 ASCO Educational Book</i> Articles:</font>
									</p>
									 
									<ul>
										<li><a href="http://click.broadcastemail.asco.org/?qs=15def1ccdbbce4762b390e06f2d2a48e45c24d81d360a0376f0ebac1ced0134d22f4cceef4e8b4e3" title="Management of Chronic Lymphocytic Leukemia" style="color: #318786; text-decoration: none;"  >Management of Chronic Lymphocytic Leukemia</a> - Dr. Stephan Stilgenbauer; Dr. Richard R. Furman; and Dr. Clive S. Zent<br /></li>
										<li><a href="http://click.broadcastemail.asco.org/?qs=a28ed4c6102bb03b425f3a488c735eb500bfe7ed94a39727241b042b7b0acf61ac77304750972f4d" title="What Can We Learn about Antibody-Drug Conjugates from the T-DM1 Experience? " style="color: #318786; text-decoration: none;"  >What Can We Learn about Antibody-Drug Conjugates from the T-DM1 Experience?</a> - Dr. Francisco J. Esteva; Dr. Kathy D. Miller; and Dr. Beverly A. Teicher</li>
										
										<li><a href="http://click.broadcastemail.asco.org/?qs=a28ed4c6102bb03b7613292995e6816ec6f89d3673336d4823f0a8b41e6e60dd02bbe65f4f4f73e2" title="New and Promising Strategies in the Management of Bladder Cancer" style="color: #318786; text-decoration: none;"  >New and Promising Strategies in the Management of Bladder Cancer</a> - Dr. Andrea B. Apolo; Dr. Nicholas J. Vogelzang; and Dr. Dan Theodorescu</li>
										<li><a href="http://click.broadcastemail.asco.org/?qs=a28ed4c6102bb03b75a4f84e810a23f7a852c903545a6d4b72c012f8a9e011a286ffb91252d4fd9a" title="Nonsurgical Management of Cervical Cancer: Locally Advanced, Recurrent, and Metastatic Disease, Survivorship, and Beyond" style="color: #318786; text-decoration: none;"  >Nonsurgical Management of Cervical Cancer: Locally Advanced, Recurrent, and Metastatic Disease, Survivorship, and Beyond</a> - Dr. Helen J. Mackay; Dr. Lari B. Wenzel; and Dr. Linda R. Mileshkin</li>
					
<li><a href="http://click.broadcastemail.asco.org/?qs=a28ed4c6102bb03be30801c87c704a7b5fb917df5a89f90321aa4447386df609dfb6722f4c481457" title="Managing Immune Checkpoint-Blocking Antibody Side Effects" style="color: #318786; text-decoration: none;"  >Managing Immune Checkpoint-Blocking Antibody Side Effects</a> - Dr. Michael A. Postow<br /></li>				
</ul>
									</td>
								</tr>
								<tr>
									<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786;">
									<a href="http://click.broadcastemail.asco.org/?qs=a28ed4c6102bb03b0814bf71d58019dca9ffed1910c99b632b9abb711bf6ee64c3c26a99ed43c7e1" style="text-decoration: none; color: #318786;" title="2015 Educational Book">Read more from the <i>2015 ASCO Educational Book </i></a><a style="text-decoration: none; color: #318786;" href="#">&#187;</a>
									</td>
								</tr>
							</tbody>
						</table>
						</td>
					</tr>
				</tbody>
			</table>
			</td>
		</tr>
		<tr>
			<td width="618" height="16" style="font-size: 1px;">&nbsp;</td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
    									</tr>
    									<tr>
    										<td width="618"></td>
    									</tr>
    									<tr>
    										<td width="618"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table cellspacing="0" cellpadding="0" class="dashedBorder">
	<tbody>
		<tr>
			<td width="618" align="left" style="background: #ffffff none repeat scroll 0% 0%;">
			<table cellspacing="0" cellpadding="0">
				<tbody>
					<tr>
						<td style="padding: 20px 24px;">
						<table cellspacing="0" cellpadding="0">
							<tbody>
								<tr>
									<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786; padding-bottom: 12px;">
									<a href="http://click.broadcastemail.asco.org/?qs=a28ed4c6102bb03b4c24b5aa51dcc4323fe891f4e755fc42a9065d11de44fc488147666c6472eb08" style="text-decoration: none; color: #318786;" title="PROCLAIM Trial: Safety Benefit with Pemetrexed Regimen in NSQ NSCLC"  >PROCLAIM Trial: Safety Benefit with Pemetrexed Regimen in NSQ NSCLC</a>
									</td>
								</tr>
								<tr>
									<td width="570" align="left">
									<table cellspacing="0" cellpadding="0">
										<tbody>
											<tr>
												<td width="284" valign="top">
												<a href="http://click.broadcastemail.asco.org/?qs=a28ed4c6102bb03b4c24b5aa51dcc4323fe891f4e755fc42a9065d11de44fc488147666c6472eb08" title="PROCLAIM Trial: Safety Benefit with Pemetrexed Regimen in NSQ NSCLC"  ><img width="284" height="148" src="http://image.broadcastemail.asco.org/lib/fe6015707d670579731c/m/1/Mon.A.7506_Senan.jpg" style="display: block; border: 0px none; width: 284px; height: 148px; margin: 0px;" title="Mon.A.7506_Senan" alt="Mon.A.7506_Senan" thid="aed37d25-15e3-4c8d-98ee-7fee46ed7e7f" /></a>
												</td>
												<td width="24" style="font-size: 1px;">&nbsp;</td>
												<td width="262" valign="top" align="left">
												<table cellspacing="0" cellpadding="0">
													<tbody>
														<tr>
															<td align="left" style="font-family: arial,sans-serif; font-size: 14px; color: #747474; padding-bottom: 16px; line-height: 18px ! important;">
In patients with advanced nonsquamous non-small cell lung cancer, a chemotherapy regimen including pemetrexed had a better safety profile than one including etoposide; however, the pemetrexed arm did not demonstrate improved OS, according to the final phase III PROCLAIM trial results (Abstract 7506), presented by Dr. Suresh Senan (pictured).</td>
														</tr>
														<tr>
															<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786;">
															<a href="http://click.broadcastemail.asco.org/?qs=a28ed4c6102bb03b4c24b5aa51dcc4323fe891f4e755fc42a9065d11de44fc488147666c6472eb08" style="text-decoration: none; color: #318786;" title="PROCLAIM Trial: Safety Benefit with Pemetrexed Regimen in NSQ NSCLC"  >Read the Full Story &#187;</a>
															</td>
														</tr>
													</tbody>
												</table>
												</td>
											</tr>
										</tbody>
									</table>
									</td>
								</tr>
							</tbody>
						</table>
						</td>
					</tr>
				</tbody>
			</table>
			</td>
		</tr>
		<tr>
			<td width="618" height="16" style="font-size: 1px;">&nbsp;</td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
    									</tr>
    									<tr>
    										<td width="618"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table cellspacing="0" cellpadding="0" class="dashedBorder">
	<tbody>
		<tr>
			<td width="618" align="left" style="background: #ffffff none repeat scroll 0% 0%;">
			<table cellspacing="0" cellpadding="0">
				<tbody>
					<tr>
						<td style="padding: 20px 24px;">
						<table cellspacing="0" cellpadding="0">
							<tbody>
								<tr>
									<td width="168" valign="top">
									<a href="http://click.broadcastemail.asco.org/?qs=a28ed4c6102bb03b8661c2784f837a25c077d26b8a66b562d94ad7219847edc5451fff4ea347f0ec" title="Clinical Trial Designs for Studying Targeted Therapies"  ><img width="168" height="174" thid="17931d5c-054f-48a7-b878-b8d6dfdce0a0" alt="Mon.A.ClinicalTrial_Simon2" title="Mon.A.ClinicalTrial_Simon2" src="http://image.broadcastemail.asco.org/lib/fe6015707d670579731c/m/1/Mon.A.ClinicalTrial_Simon2.jpg" style="display: block; border: 0px none; width: 168px; height: 174px; margin: 0px;" /></a>
									</td>
									<td width="24" style="font-size: 1px;">&nbsp;</td>
									<td width="378" valign="top" align="left">
									<table cellspacing="0" cellpadding="0">
										<tbody>
											<tr>
												<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786; padding-bottom: 12px;">
												<a href="http://click.broadcastemail.asco.org/?qs=a28ed4c6102bb03b8661c2784f837a25c077d26b8a66b562d94ad7219847edc5451fff4ea347f0ec" style="text-decoration: none; color: #318786;" title="Clinical Trial Designs for Studying Targeted Therapies"  >Clinical Trial Designs for Studying Targeted Therapies</a>
												</td>
											</tr>
											<tr>
												<td align="left" style="font-family: arial,sans-serif; font-size: 14px; color: #747474; padding-bottom: 16px; line-height: 18px ! important;">
During the Education Session "Improving Clinical Trial Efficiency: Thinking Outside the Box," 
												Drs. Richard Simon (pictured), Sumithra J. Mandrekar, and Suzanne Dahlberg discussed several strategies to address the challenge of understanding drug activity in molecularly defined subsets of patients. <br /></td>
											</tr>
											<tr>
												<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786;">
												<a href="http://click.broadcastemail.asco.org/?qs=a28ed4c6102bb03b8661c2784f837a25c077d26b8a66b562d94ad7219847edc5451fff4ea347f0ec" style="text-decoration: none; color: #318786;" title="Clinical Trial Designs for Studying Targeted Therapies"  >Read the Full Story &#187;</a>
												</td>
											</tr>
										</tbody>
									</table>
									</td>
								</tr>
							</tbody>
						</table>
						</td>
					</tr>
				</tbody>
			</table>
			</td>
		</tr>
		<tr>
			<td width="618" height="16" style="font-size: 1px;">&nbsp;</td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
    									</tr>
    									<tr>
    										<td width="618"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table cellspacing="0" cellpadding="0" class="dashedBorder">
	<tbody>
		<tr>
			<td width="618" align="left" style="background: #ffffff none repeat scroll 0% 0%;">
			<table cellspacing="0" cellpadding="0">
				<tbody>
					<tr>
						<td style="padding: 20px 24px;">
						<table cellspacing="0" cellpadding="0">
							<tbody>
								<tr>
									<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786; padding-bottom: 12px;">
									<a style="text-decoration: none; color: #318786;" href="http://click.broadcastemail.asco.org/?qs=a28ed4c6102bb03bf667e3526a9dd0176495e0fd45efeae1da77dde03cae749d4c9ca9d5763f5f02" title="Opportunities and Challenges of Incorporating Technology into Practice"  >Opportunities and Challenges of Incorporating Technology into Practice</a>
									</td>
								</tr>
								<tr>
									<td width="570" align="left">
									<table cellspacing="0" cellpadding="0">
										<tbody>
											<tr>
												<td width="284" valign="top">
												<a   title="Opportunities and Challenges of Incorporating Technology into Practice" href="http://click.broadcastemail.asco.org/?qs=a28ed4c6102bb03bf667e3526a9dd0176495e0fd45efeae1da77dde03cae749d4c9ca9d5763f5f02"><img width="284" height="148" alt="Mon.A.Tech_Thompson" title="Mon.A.Tech_Thompson" style="display: block; border: 0px none; width: 284px; height: 148px; margin: 0px;" src="http://image.broadcastemail.asco.org/lib/fe6015707d670579731c/m/1/Mon.A.Tech_Thompson.jpg" thid="5219cbd4-f101-4d74-9c60-4de55845ded0" /></a>
												</td>
												<td width="24" style="font-size: 1px;">&nbsp;</td>
												<td width="262" valign="top" align="left">
												<table cellspacing="0" cellpadding="0">
													<tbody>
														<tr>
															<td align="left" style="font-family: arial,sans-serif; font-size: 14px; color: #747474; padding-bottom: 16px; line-height: 18px ! important;">
During the Education Session "The Challenge to Stay Current: Incorporating Technology into Practice," Dr. Michael A. Thompson (pictured), Dr. Jeremy Warner, and Dr. Laura E. Strong explored topics related to information retrieval, social media, and the application of technology to patient-reported outcomes.
															</td>
														</tr>
														<tr>
															<td align="left" style="font-family: arial,sans-serif; font-size: 18px; font-weight: bold; color: #318786;">
															<a   title="Opportunities and Challenges of Incorporating Technology into Practice" style="text-decoration: none; color: #318786;" href="http://click.broadcastemail.asco.org/?qs=a28ed4c6102bb03bf667e3526a9dd0176495e0fd45efeae1da77dde03cae749d4c9ca9d5763f5f02">Read the Full Story &#187;</a>
															</td>
														</tr>
													</tbody>
												</table>
												</td>
											</tr>
										</tbody>
									</table>
									</td>
								</tr>
							</tbody>
						</table>
						</td>
					</tr>
				</tbody>
			</table>
			</td>
		</tr>
		<tr>
			<td width="618" height="16" style="font-size: 1px;">&nbsp;</td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
    									</tr>
    									<tr>
    										<td width="618"></td>
    									</tr>
									    <tr>
									    	<td width="618"></td>
									    </tr>
									    <tr>
									    	<td width="618"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table cellspacing="0" cellpadding="0" class="dashedBorder">
	<tbody>
		<tr>
			<td width="618" align="center" style="border-top: 1px solid #ffffff; border-bottom: 2px solid #ffffff; padding: 12px 0px; background: #d2e8e2 none repeat scroll 0% 0%;">
			<table cellspacing="0" cellpadding="0">
				<tbody>
					<tr>
						<td align="center" style="font-family: arial,sans-serif; font-size: 16px; font-weight: bold; color: #6a6a6a; line-height: 30px ! important;">
						<a   href="http://click.broadcastemail.asco.org/?qs=a28ed4c6102bb03ba48dbe167030d31336d6ceadfb516e4f7e3a110a76427e0028b1a8d325f28419" style="text-decoration: none; color: #318786;" title="https://am.asco.org/daily-news"><i>ASCO Daily News</i> Home</a><a href="http://click.broadcastemail.asco.org/?qs=a28ed4c6102bb03bd43f283003168cc8892640b1b5aa1b054d8e3873473b5db58d077843b30720c1b5f76100da647299" title="ASCO Daily News Home"  ></a> | <a href="http://click.broadcastemail.asco.org/?qs=37b07e9cc1958bd810a53561c987d1ffe46591b3723f88c1af5d16fc3495f34959082fd5d5baabf8e1adf1516cbc5f8c" style="text-decoration: none; color: #318786;" title="Session coverage"  >Session Coverage</a> | <a href="http://click.broadcastemail.asco.org/?qs=37b07e9cc1958bd8e6efa12e31453eaa1b1c371b112fc54a70e7cb99dc152c73c6b63c9b5b7a7be386f38bec3e5f6e85" style="text-decoration: none; color: #318786;" title="Expert editorials"  >Expert Editorials</a>
						</td>
					</tr>
					<tr>
						<td align="center" style="font-family: arial,sans-serif; font-size: 16px; font-weight: bold; color: #6a6a6a; line-height: 30px ! important;">
						<a href="http://click.broadcastemail.asco.org/?qs=37b07e9cc1958bd8771415172debbc20d7eada1865ceadefaae981718c1aaa2d19e85cb311122a6df7646d22db958d5d" style="text-decoration: none; color: #318786;" title="Grants and Awards"  >Grants and Awards</a> | <a href="http://click.broadcastemail.asco.org/?qs=37b07e9cc1958bd839ff930caff24bf4f72cff2d8b733ab27e3cfa6b8217f6840e813c517023b1ef0fa082554aca6406" style="text-decoration: none; color: #318786;" title="am.asco.org"  >am.asco.org</a>
						</td>
					</tr>
				</tbody>
			</table>
			</td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
									    </tr>
									    <tr>
									    	<td width="618"><table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><table cellpadding="0" cellspacing="0" class="dashedBorder">
	<tbody>
		<tr>
			<td width="618" align="center" style="padding: 12px 0px; background: #efefef;">
			<table cellpadding="0" cellspacing="0">
				<tbody>
					<tr>
						<td style="font-family: arial, sans-serif; font-size: 16px; color: #575757; padding-right: 10px;">Connect with us:</td>
						<td style="padding-right: 10px;"><a href="http://click.broadcastemail.asco.org/?qs=37b07e9cc1958bd888ece2b06bf4db1a5fbf653c42039752c6a44e9f09dd43e846d53f26339f1fcda1f2c313a690a8e6" title="Twitter"  ><img src="http://image.broadcastemail.asco.org/lib/fe66157077670d7f7712/m/1/eDigest_11.jpg" style="display: block; border: 0px; width: 32px; height: 32px; margin: 0px;" width="32" height="32" /></a></td>
						<td style="padding-right: 10px;"><a href="http://click.broadcastemail.asco.org/?qs=37b07e9cc1958bd88c0097286556f593453e6c9dc9a8754a23058cd393069a89939018cccbd9b3986301e156b214f9db" title="Facebook"  ><img src="http://image.broadcastemail.asco.org/lib/fe66157077670d7f7712/m/1/eDigest_13.jpg" style="display: block; border: 0px; width: 32px; height: 32px; margin: 0px;" width="32" height="32" /></a></td>
						<td style="padding-right: 10px;"><a href="http://click.broadcastemail.asco.org/?qs=37b07e9cc1958bd8b850b5497b7669c873ac1eb744b6f695d5ab1ec3998450f510768cb4a4d16f4e1d39ef7fcccb5813" title="Linkedin"  ><img src="http://image.broadcastemail.asco.org/lib/fe66157077670d7f7712/m/1/eDigest_15.jpg" style="display: block; border: 0px; width: 32px; height: 32px; margin: 0px;" width="32" height="32" /></a></td>
						<td style="padding-right: 20px;"></td>
						<td style="font-family: arial, sans-serif; font-size: 16px; color: #575757; padding-right: 10px;">
						<a href="http://click.broadcastemail.asco.org/?qs=37b07e9cc1958bd8b516d914b29d9d9c9d3d1ca3cffe33b0caf2e690c46d2ea4c8aab564c8ef2292" style="text-decoration: none; color: #318786;">Forward to a Colleague</a>
						</td>
						<td><a href="http://click.broadcastemail.asco.org/?qs=37b07e9cc1958bd8b516d914b29d9d9c9d3d1ca3cffe33b0caf2e690c46d2ea4c8aab564c8ef2292"><img src="http://image.broadcastemail.asco.org/lib/fe66157077670d7f7712/m/1/eDigest_19.jpg" alt="Email" style="display: block; border: 0px;" /></a></td>
					</tr>
				</tbody>
			</table>
			</td>
		</tr>
	</tbody>
</table></td></tr></table></td></tr></table></td>
									    </tr>
    								</table>
    							</td>
    							<td width="16" style="font-size: 1px; min-width: 16px;">&nbsp;</td>
    							<td width="160" valign="top">
    								<table cellpadding="0" cellspacing="0" border="0" bordercolor="" width="100%" bgcolor=""><tr><td><table  width="100%" bgcolor="" border="0" bordercolor="" cellpadding="0" cellspacing="0"><tr><td style="font-family:Arial; font-size:13px"><div align="center"><a   title="Counquer Cancer Foundation" href="http://click.broadcastemail.asco.org/?qs=37b07e9cc1958bd859ac0bf2f9b939451637df6321dafa0daeeb4b0309efbd0bc632a463ab885190">
<img width="160" height="600" border="0" mdid="c585d900-cab4-4ae1-9ea1-872ee29f4337" style="width: 160px; height: 600px; border-color: #000000; margin: 0px;" src="http://image.broadcastemail.asco.org/lib/fe6015707d670579731c/m/1/033566_ascocf_HCP_BannerAds_Type_160x600_lo1op2.jpg" title="033566_ascocf_HCP_BannerAds_Type_160x600_lo1op2" alt="033566_ascocf_HCP_BannerAds_Type_160x600_lo1op2" /></a><br />Advertisement</div></td></tr></table></td></tr></table>
    							</td>
    						</tr>
    					</table>
    				</td>
    			</tr>
    		</table>
    	</td>
    </tr>
    <tr>
    	<td class="disclaimer" width="826" align="center">
    		
    	</td>
    </tr>
</table>
                        </td>
                    </tr>
                    <tr>
                      
                                            </tr>
                                        </table>
                                    </td>
                                </tr>
                            </table>
                        </td>
                    </tr>
                </table>
            </td>
        </tr>
    </table>

    <!-- Exact Target tracking code -->
    <img src="http://click.broadcastemail.asco.org/open.aspx?ffcb10-fe5b1776746700747217-fdc61574706c037c7112727664-fe6015707d670579731c-fe6415787165027c7710-fe271d7877640475761579-ff5e10747c" width="1" height="1">

</body>
 <!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<title></title>
</head><body style="background: #d8d8d8;font-family:Arial, Helvetica, sans-serif; font-size:1em;">
<body>


<div width="850" style="margin-left: auto; margin-right: auto; width: 850px; text-align: left;">

You are receiving this email because you have an existing relationship
with ASCO.&nbsp; Visit your personalized <a
href="http://click.broadcastemail.asco.org/?qs=37b07e9cc1958bd86561728786fc156ef0872f863518ea82bdfed3a5a5c76ad2e60e0696bcb9e03a"
target="_blank">Preference Center</a> to unsubscribe or to select
your preferences for receiving ASCO promotional email.&nbsp; Please do
not reply to this email.&nbsp; <br>
This email was sent by: American Society of Clinical Oncology<br>
2318 Mill Road, Suite 800 Alexandria, VA,
22314, USA<br></div>
</body>
</body>
</html>

--D3aH951gzsxU=_?:--

